Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Håvik Annette"'
Autor:
Håvik Annette, Brandal Petter, Honne Hilde, Dahlback Hanne-Sofie, Scheie David, Hektoen Merete, Meling Torstein, Helseth Eirik, Heim Sverre, Lothe Ragnhild A, Lind Guro
Publikováno v:
Journal of Translational Medicine, Vol 10, Iss 1, p 36 (2012)
Abstract Background Methylation of the O6-methylguanine-DNA methyltransferase (MGMT) gene promoter is a favorable prognostic factor in glioblastoma patients. However, reported methylation frequencies vary significantly partly due to lack of consensus
Externí odkaz:
https://doaj.org/article/92d6f74733234a09a3136c00cb8ea31b
Autor:
Jeanmougin, Marine, Håvik, Annette Bentsen, Cekaite, Lina, Brandal, Petter, Sveen, Anita, Meling, Torstein Ragnar, Ågesen, Trude Holmeide, Scheie, David, Heim, Sverre, Lothe, Ragnhild A, Lind, Guro Elisabeth
Publikováno v:
Jeanmougin, Marine Håvik, Annette Bentsen Cekaite, Lina Brandal, Petter Sveen, Anita Meling, Torstein Ragnar Ågesen, Trude Holmeide Scheie, David Heim, Sverre Lothe, Ragnhild A Lind, Guro Elisabeth . Improved prognostication of glioblastoma beyond molecular subtyping by transcriptional profiling of the tumor microenvironment. Molecular Oncology. 2020, 1016-1027
Molecular Oncology
Molecular Oncology
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jeanmougin M; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital - The Norwegian Radium Hospital, Oslo, Norway., Håvik AB; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital - The Norwegian Radium Hospital, Oslo, Norway.; Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, Oslo University Hospital - The Norwegian Radium Hospital, Oslo, Norway., Cekaite L; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital - The Norwegian Radium Hospital, Oslo, Norway., Brandal P; Department of Oncology, Oslo University Hospital - The Norwegian Radium Hospital, Oslo, Norway., Sveen A; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital - The Norwegian Radium Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Meling TR; Department of Neurosurgery, Oslo University Hospital - Rikshospitalet, Oslo, Norway., Ågesen TH; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital - The Norwegian Radium Hospital, Oslo, Norway., Scheie D; Department of Pathology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark., Heim S; Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, Oslo University Hospital - The Norwegian Radium Hospital, Oslo, Norway., Lothe RA; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital - The Norwegian Radium Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Lind GE; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital - The Norwegian Radium Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Publikováno v:
Molecular oncology [Mol Oncol] 2020 May; Vol. 14 (5), pp. 1016-1027. Date of Electronic Publication: 2020 Apr 04.